Society of Utah Medical Oncology

Welcome

Our primary mission is to promote the highest professional standards of oncology practice in the state of Utah; to study, research and exchange information, leading to improvement in the practice of hematology; to support and further oncology education; and to monitor and respond to appropriate legislative and regulatory concerns of the membership.

We encourage all oncology professionals to find out more about us and become a member of our growing community.

The Benefits of Membership

Become a member of the Society of Utah Medical Oncologists and enjoy these member only benefits:

  • Only professional organization that represents all hematology and oncology specialties and practices in Utah
  • Advocates on behalf of members on reimbursement and other issues
  • Provides a business meeting in the spring and a 1.5 day clinical meeting in the fall
  • Provides representation on legislative issues
  • Shares resources with other oncology-related organizations
  • Community outreach includes the University of Utah Oncology Interest Group for medical students
  • Acts as the institutional memory for the oncology community
  • Maintains a comprehensive database of member information
  • Collaborates with other state oncology societies, ASCO, COA, ASH and other entities as needed
  • Provides a comprehensive website
Join Today

CMS Releases Physician Fee Schedule Final Rule
The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Physician Fee Schedule (PFS) rule. The agency responded to the overwhelming negative stakeholder response to its proposal to revise evaluation and management (E/M) documentation requirements and payment by significantly revising its final policy.

Click here for more.

CMS Releases Final Hospital Outpatient Payment Rule - The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Hospital Outpatient Prospective Payment System (OPPS) rule. In the Society’s comment letter, ASH requested that CMS change the status indicator for the four new Category III CPT codes for chimeric antigen receptor (CAR) T-cell therapy from “B” to “S.” In the final rule, CMS did finalize this change for one of the four codes, code 0540T, CAR-T cell administration, autologous. 

Click here for the report.

 

Upcoming Events

ASCO Webinar Planned 

On February 15 from 11:00 AM - 12:00 PM ET, ASCO will host a webinar discussing current standards for the safe handling of hazardous drugs. The webinar will look at existing safe handling standards from the United States Pharmacopeia (USP) and the National Institute for Occupational Safety and Health (NIOSH), and provide an overview of ASCO’s recently released standards.

Click here for more!

Save the Date for 2019 Spring Meeting

2019 SUMO Spring Business Meeting 
April 23, 2019.
Salt Lake City Marriott City Center, 220 S State St, Salt Lake City, UT  84111.
 2019 SUMO Fall Meeting
September 27 -28, 2019
Hyatt Centric Park City, 3551 N Escala Ct, Park City, UT 84098
ASCO has announced fifteen distinguished members selected by the Nominating Committee as candidates for open leadership positions within the Society. From November 1 to December 3, 2018, eligible ASCO members are encouraged to vote to choose new leaders and on proposed amendments to the ASCO Bylaws. To learn more about the candidates, click here and log into your ASCO account.

8 Medicare and Medicaid reforms that would have the biggest impact on federal spending

Click here for more